Prevalence and management of driveline infections in mechanical circulatory support - a single center analysis

Abstract Background Driveline infections in continuous-flow left ventricular assist devices (cf-LVAD) remain the most common adverse event. This single-center retrospective study investigated the risk factors, prevalence and management of driveline infections. Methods Patients treated after cf-LVAD...

Full description

Bibliographic Details
Main Authors: Andrzej Juraszek, Mikołaj Smólski, Piotr Kołsut, Jarosław Szymański, Paweł Litwiński, Krzysztof Kuśmierski, Joanna Zakrzewska-Koperska, Maciej Sterliński, Tomasz Dziodzio, Mariusz Kuśmierczyk
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Online Access:https://doi.org/10.1186/s13019-021-01589-6
_version_ 1818607250675073024
author Andrzej Juraszek
Mikołaj Smólski
Piotr Kołsut
Jarosław Szymański
Paweł Litwiński
Krzysztof Kuśmierski
Joanna Zakrzewska-Koperska
Maciej Sterliński
Tomasz Dziodzio
Mariusz Kuśmierczyk
author_facet Andrzej Juraszek
Mikołaj Smólski
Piotr Kołsut
Jarosław Szymański
Paweł Litwiński
Krzysztof Kuśmierski
Joanna Zakrzewska-Koperska
Maciej Sterliński
Tomasz Dziodzio
Mariusz Kuśmierczyk
author_sort Andrzej Juraszek
collection DOAJ
description Abstract Background Driveline infections in continuous-flow left ventricular assist devices (cf-LVAD) remain the most common adverse event. This single-center retrospective study investigated the risk factors, prevalence and management of driveline infections. Methods Patients treated after cf-LVAD implantation from December 2014 to January 2020 were enrolled. Baseline data were collected and potential risk factors were elaborated. The multi-modal treatment was based on antibiotic therapy, daily wound care, surgical driveline reposition, and heart transplantation. Time of infection development, freedom of reinfection, freedom of heart transplantation, and death in the follow-up time were investigated. Results Of 75 observed patients, 26 (34.7%) developed a driveline infection. The mean time from implantation to infection diagnosis was 463 (±399; range, 35–1400) days. The most common pathogen was Staphylococcus aureus (n = 15, 60%). First-line therapy was based on antibiotics, with a primary success rate of 27%. The majority of patients (n = 19; 73.1%) were treated with surgical reposition after initial antibiotic therapy. During the follow-up time of 569 (±506; range 32–2093) days, the reinfection freedom after surgical transposition was 57.9%. Heart transplantation was performed in eight patients due to resistant infection. The overall mortality for driveline infection was 11.5%. Conclusions Driveline infections are frequent in patients with implanted cf-LVAD, and treatment does not efficiently avoid reinfection, leading to moderate mortality rates. Only about a quarter of the infected patients were cured with antibiotics alone. Surgical driveline reposition is a reasonable treatment option and does not preclude subsequent heart transplantation due to limited reinfection freedom.
first_indexed 2024-12-16T14:23:46Z
format Article
id doaj.art-c5c3b4651bfc4e30b567f3a5bd095c39
institution Directory Open Access Journal
issn 1749-8090
language English
last_indexed 2024-12-16T14:23:46Z
publishDate 2021-08-01
publisher BMC
record_format Article
series Journal of Cardiothoracic Surgery
spelling doaj.art-c5c3b4651bfc4e30b567f3a5bd095c392022-12-21T22:28:26ZengBMCJournal of Cardiothoracic Surgery1749-80902021-08-011611810.1186/s13019-021-01589-6Prevalence and management of driveline infections in mechanical circulatory support - a single center analysisAndrzej Juraszek0Mikołaj Smólski1Piotr Kołsut2Jarosław Szymański3Paweł Litwiński4Krzysztof Kuśmierski5Joanna Zakrzewska-Koperska6Maciej Sterliński7Tomasz Dziodzio8Mariusz Kuśmierczyk9Department of Cardiac Surgery and Transplantation, The Cardinal Stefan Wyszyński National Institute of CardiologyMedical University of WarsawDepartment of Cardiac Surgery and Transplantation, The Cardinal Stefan Wyszyński National Institute of CardiologyDepartment of Cardiac Surgery and Transplantation, The Cardinal Stefan Wyszyński National Institute of CardiologyDepartment of Cardiac Surgery and Transplantation, The Cardinal Stefan Wyszyński National Institute of CardiologyDepartment of Cardiac Surgery and Transplantation, The Cardinal Stefan Wyszyński National Institute of Cardiology1st Department of Arrhythmia, The Cardinal Stefan Wyszyński National Institute of Cardiology1st Department of Arrhythmia, The Cardinal Stefan Wyszyński National Institute of CardiologyDepartment of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum Charité –Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of HealthDepartment of Cardiac Surgery and Transplantation, The Cardinal Stefan Wyszyński National Institute of CardiologyAbstract Background Driveline infections in continuous-flow left ventricular assist devices (cf-LVAD) remain the most common adverse event. This single-center retrospective study investigated the risk factors, prevalence and management of driveline infections. Methods Patients treated after cf-LVAD implantation from December 2014 to January 2020 were enrolled. Baseline data were collected and potential risk factors were elaborated. The multi-modal treatment was based on antibiotic therapy, daily wound care, surgical driveline reposition, and heart transplantation. Time of infection development, freedom of reinfection, freedom of heart transplantation, and death in the follow-up time were investigated. Results Of 75 observed patients, 26 (34.7%) developed a driveline infection. The mean time from implantation to infection diagnosis was 463 (±399; range, 35–1400) days. The most common pathogen was Staphylococcus aureus (n = 15, 60%). First-line therapy was based on antibiotics, with a primary success rate of 27%. The majority of patients (n = 19; 73.1%) were treated with surgical reposition after initial antibiotic therapy. During the follow-up time of 569 (±506; range 32–2093) days, the reinfection freedom after surgical transposition was 57.9%. Heart transplantation was performed in eight patients due to resistant infection. The overall mortality for driveline infection was 11.5%. Conclusions Driveline infections are frequent in patients with implanted cf-LVAD, and treatment does not efficiently avoid reinfection, leading to moderate mortality rates. Only about a quarter of the infected patients were cured with antibiotics alone. Surgical driveline reposition is a reasonable treatment option and does not preclude subsequent heart transplantation due to limited reinfection freedom.https://doi.org/10.1186/s13019-021-01589-6Driveline infectionLeft ventricular assist deviceSurgical reposition
spellingShingle Andrzej Juraszek
Mikołaj Smólski
Piotr Kołsut
Jarosław Szymański
Paweł Litwiński
Krzysztof Kuśmierski
Joanna Zakrzewska-Koperska
Maciej Sterliński
Tomasz Dziodzio
Mariusz Kuśmierczyk
Prevalence and management of driveline infections in mechanical circulatory support - a single center analysis
Journal of Cardiothoracic Surgery
Driveline infection
Left ventricular assist device
Surgical reposition
title Prevalence and management of driveline infections in mechanical circulatory support - a single center analysis
title_full Prevalence and management of driveline infections in mechanical circulatory support - a single center analysis
title_fullStr Prevalence and management of driveline infections in mechanical circulatory support - a single center analysis
title_full_unstemmed Prevalence and management of driveline infections in mechanical circulatory support - a single center analysis
title_short Prevalence and management of driveline infections in mechanical circulatory support - a single center analysis
title_sort prevalence and management of driveline infections in mechanical circulatory support a single center analysis
topic Driveline infection
Left ventricular assist device
Surgical reposition
url https://doi.org/10.1186/s13019-021-01589-6
work_keys_str_mv AT andrzejjuraszek prevalenceandmanagementofdrivelineinfectionsinmechanicalcirculatorysupportasinglecenteranalysis
AT mikołajsmolski prevalenceandmanagementofdrivelineinfectionsinmechanicalcirculatorysupportasinglecenteranalysis
AT piotrkołsut prevalenceandmanagementofdrivelineinfectionsinmechanicalcirculatorysupportasinglecenteranalysis
AT jarosławszymanski prevalenceandmanagementofdrivelineinfectionsinmechanicalcirculatorysupportasinglecenteranalysis
AT pawełlitwinski prevalenceandmanagementofdrivelineinfectionsinmechanicalcirculatorysupportasinglecenteranalysis
AT krzysztofkusmierski prevalenceandmanagementofdrivelineinfectionsinmechanicalcirculatorysupportasinglecenteranalysis
AT joannazakrzewskakoperska prevalenceandmanagementofdrivelineinfectionsinmechanicalcirculatorysupportasinglecenteranalysis
AT maciejsterlinski prevalenceandmanagementofdrivelineinfectionsinmechanicalcirculatorysupportasinglecenteranalysis
AT tomaszdziodzio prevalenceandmanagementofdrivelineinfectionsinmechanicalcirculatorysupportasinglecenteranalysis
AT mariuszkusmierczyk prevalenceandmanagementofdrivelineinfectionsinmechanicalcirculatorysupportasinglecenteranalysis